Indicator type	Execution Sectors	Total
Units carrying out R&D in Biotechnology	Total	1,802
Units carrying out R&D in Biotechnology	Public Administration	119
Units carrying out R&D in Biotechnology	Higher Education	68
Units carrying out R&D in Biotechnology	Companies	1,602
Units carrying out R&D in Biotechnology	NPPI	13
% Units by type of biotechnology used: Genetic Code	Total	35.0
% Units by type of biotechnology used: Genetic Code	Public Administration	86.5
% Units by type of biotechnology used: Genetic Code	Higher Education	92.7
% Units by type of biotechnology used: Genetic Code	Companies	28.8
% Units by type of biotechnology used: Genetic Code	NPPI	23.1
% Units by type of biotechnology used: Functional Units	Total	43.9
% Units by type of biotechnology used: Functional Units	Public Administration	81.5
% Units by type of biotechnology used: Functional Units	Higher Education	97.1
% Units by type of biotechnology used: Functional Units	Companies	38.9
% Units by type of biotechnology used: Functional Units	NPPI	30.8
% Units by type of biotechnology used: Cell and Tissue Culture and Engineering	Total	26.9
% Units by type of biotechnology used: Cell and Tissue Culture and Engineering	Public Administration	66.4
% Units by type of biotechnology used: Cell and Tissue Culture and Engineering	Higher Education	82.3
% Units by type of biotechnology used: Cell and Tissue Culture and Engineering	Companies	21.5
% Units by type of biotechnology used: Cell and Tissue Culture and Engineering	NPPI	38.5
% Units by type of biotechnology used: Bioprocesses	Total	51.8
% Units by type of biotechnology used: Bioprocesses	Public Administration	58.8
% Units by type of biotechnology used: Bioprocesses	Higher Education	91.2
% Units by type of biotechnology used: Bioprocesses	Companies	49.5
% Units by type of biotechnology used: Bioprocesses	NPPI	53.9
% Units by type of biotechnology used: Subcellular Organisms	Total	13.8
% Units by type of biotechnology used: Subcellular Organisms	Public Administration	51.3
% Units by type of biotechnology used: Subcellular Organisms	Higher Education	66.2
% Units by type of biotechnology used: Subcellular Organisms	Companies	8.7
% Units by type of biotechnology used: Subcellular Organisms	NPPI	23.1
% Units by type of biotechnology used: Bioinformatics	Total	32.0
% Units by type of biotechnology used: Bioinformatics	Public Administration	70.6
% Units by type of biotechnology used: Bioinformatics	Higher Education	88.2
% Units by type of biotechnology used: Bioinformatics	Companies	26.9
% Units by type of biotechnology used: Bioinformatics	NPPI	23.1
% Units by type of biotechnology used: Nanobiotechnology	Total	16.9
% Units by type of biotechnology used: Nanobiotechnology	Public Administration	53.8
% Units by type of biotechnology used: Nanobiotechnology	Higher Education	75.0
% Units by type of biotechnology used: Nanobiotechnology	Companies	11.8
% Units by type of biotechnology used: Nanobiotechnology	NPPI	7.7
% Units by type of biotechnology used: Other	Total	17.1
% Units by type of biotechnology used: Other	Public Administration	8.4
% Units by type of biotechnology used: Other	Higher Education	8.8
% Units by type of biotechnology used: Other	Companies	18.0
% Units by type of biotechnology used: Other	NPPI	23.1
Units in which biotechnology activities are: Main and/or exclusive	Total	822
Units in which biotechnology activities are: Main and/or exclusive	Public Administration	36
Units in which biotechnology activities are: Main and/or exclusive	Higher Education	6
Units in which biotechnology activities are: Main and/or exclusive	Companies	773
Units in which biotechnology activities are: Main and/or exclusive	NPPI	7
Units in which biotechnology activities are: A secondary business line	Total	366
Units in which biotechnology activities are: A secondary business line	Public Administration	45
Units in which biotechnology activities are: A secondary business line	Higher Education	40
Units in which biotechnology activities are: A secondary business line	Companies	279
Units in which biotechnology activities are: A secondary business line	NPPI	2
Units in which biotechnology activities are: A necessary tool for production	Total	614
Units in which biotechnology activities are: A necessary tool for production	Public Administration	38
Units in which biotechnology activities are: A necessary tool for production	Higher Education	22
Units in which biotechnology activities are: A necessary tool for production	Companies	550
Units in which biotechnology activities are: A necessary tool for production	NPPI	4
% Units by final application areas of biotechnology use: Human Health	Total	52.1
% Units by final application areas of biotechnology use: Human Health	Public Administration	78.2
% Units by final application areas of biotechnology use: Human Health	Higher Education	91.2
% Units by final application areas of biotechnology use: Human Health	Companies	48.4
% Units by final application areas of biotechnology use: Human Health	NPPI	69.2
% Units by final application areas of biotechnology use: Animal Health and Aquaculture	Total	20.8
% Units by final application areas of biotechnology use: Animal Health and Aquaculture	Public Administration	21.0
% Units by final application areas of biotechnology use: Animal Health and Aquaculture	Higher Education	60.3
% Units by final application areas of biotechnology use: Animal Health and Aquaculture	Companies	19.1
% Units by final application areas of biotechnology use: Animal Health and Aquaculture	NPPI	15.4
% Units by final application areas of biotechnology use: Food Products	Total	30.2
% Units by final application areas of biotechnology use: Food Products	Public Administration	23.5
% Units by final application areas of biotechnology use: Food Products	Higher Education	77.9
% Units by final application areas of biotechnology use: Food Products	Companies	28.9
% Units by final application areas of biotechnology use: Food Products	NPPI	0.0
% Units by final application areas of biotechnology use: Agriculture and Forestry	Total	26.3
% Units by final application areas of biotechnology use: Agriculture and Forestry	Public Administration	22.7
% Units by final application areas of biotechnology use: Agriculture and Forestry	Higher Education	70.6
% Units by final application areas of biotechnology use: Agriculture and Forestry	Companies	24.8
% Units by final application areas of biotechnology use: Agriculture and Forestry	NPPI	7.7
% Units by final application areas of biotechnology use: Environment	Total	20.9
% Units by final application areas of biotechnology use: Environment	Public Administration	23.5
% Units by final application areas of biotechnology use: Environment	Higher Education	76.5
% Units by final application areas of biotechnology use: Environment	Companies	18.2
% Units by final application areas of biotechnology use: Environment	NPPI	30.8
% Units by final application areas of biotechnology use: Industry	Total	15.7
% Units by final application areas of biotechnology use: Industry	Public Administration	15.1
% Units by final application areas of biotechnology use: Industry	Higher Education	70.6
% Units by final application areas of biotechnology use: Industry	Companies	13.5
% Units by final application areas of biotechnology use: Industry	NPPI	7.7
R&D personnel in Biotechnology (PP)	Total	54,261
R&D personnel in Biotechnology (PP)	Public Administration	16,196
R&D personnel in Biotechnology (PP)	Higher Education	18,508
R&D personnel in Biotechnology (PP)	Companies	19,307
R&D personnel in Biotechnology (PP)	NPPI	250
R&D personnel in Biotechnology (PP): Research personnel	Total	34,806
R&D personnel in Biotechnology (PP): Research personnel	Public Administration	9,453
R&D personnel in Biotechnology (PP): Research personnel	Higher Education	14,417
R&D personnel in Biotechnology (PP): Research personnel	Companies	10,779
R&D personnel in Biotechnology (PP): Research personnel	NPPI	157
R&D personnel in Biotechnology (PP): Technical and auxiliary personnel	Total	19,455
R&D personnel in Biotechnology (PP): Technical and auxiliary personnel	Public Administration	6,743
R&D personnel in Biotechnology (PP): Technical and auxiliary personnel	Higher Education	4,091
R&D personnel in Biotechnology (PP): Technical and auxiliary personnel	Companies	8,528
R&D personnel in Biotechnology (PP): Technical and auxiliary personnel	NPPI	93
R&D personnel in Biotechnology (PP). Women	Total	31,521
R&D personnel in Biotechnology (PP). Women	Public Administration	10,361
R&D personnel in Biotechnology (PP). Women	Higher Education	9,841
R&D personnel in Biotechnology (PP). Women	Companies	11,155
R&D personnel in Biotechnology (PP). Women	NPPI	164
R&D personnel in Biotechnology (PP). Women: Research personnel	Total	19,227
R&D personnel in Biotechnology (PP). Women: Research personnel	Public Administration	5,763
R&D personnel in Biotechnology (PP). Women: Research personnel	Higher Education	7,437
R&D personnel in Biotechnology (PP). Women: Research personnel	Companies	5,934
R&D personnel in Biotechnology (PP). Women: Research personnel	NPPI	93
R&D personnel in Biotechnology (PP). Women: Technical and auxiliary personnel	Total	12,295
R&D personnel in Biotechnology (PP). Women: Technical and auxiliary personnel	Public Administration	4,598
R&D personnel in Biotechnology (PP). Women: Technical and auxiliary personnel	Higher Education	2,404
R&D personnel in Biotechnology (PP). Women: Technical and auxiliary personnel	Companies	5,222
R&D personnel in Biotechnology (PP). Women: Technical and auxiliary personnel	NPPI	71
R&D personnel in Biotechnology (FTE)	Total	39,780.6
R&D personnel in Biotechnology (FTE)	Public Administration	13,083.5
R&D personnel in Biotechnology (FTE)	Higher Education	12,414.8
R&D personnel in Biotechnology (FTE)	Companies	14,093.7
R&D personnel in Biotechnology (FTE)	NPPI	188.6
R&D personnel in Biotechnology (FTE): Research personnel	Total	25,414.2
R&D personnel in Biotechnology (FTE): Research personnel	Public Administration	7,515.4
R&D personnel in Biotechnology (FTE): Research personnel	Higher Education	9,705.9
R&D personnel in Biotechnology (FTE): Research personnel	Companies	8,073.8
R&D personnel in Biotechnology (FTE): Research personnel	NPPI	119.1
R&D personnel in Biotechnology (FTE): Technical and auxiliary personnel	Total	14,366.4
R&D personnel in Biotechnology (FTE): Technical and auxiliary personnel	Public Administration	5,568.1
R&D personnel in Biotechnology (FTE): Technical and auxiliary personnel	Higher Education	2,708.9
R&D personnel in Biotechnology (FTE): Technical and auxiliary personnel	Companies	6,019.9
R&D personnel in Biotechnology (FTE): Technical and auxiliary personnel	NPPI	69.5
R&D personnel in Biotechnology (FTE). Women	Total	23,767.2
R&D personnel in Biotechnology (FTE). Women	Public Administration	8,412.7
R&D personnel in Biotechnology (FTE). Women	Higher Education	6,920.0
R&D personnel in Biotechnology (FTE). Women	Companies	8,305.8
R&D personnel in Biotechnology (FTE). Women	NPPI	128.7
R&D personnel in Biotechnology (FTE). Women: Research personnel	Total	14,450.6
R&D personnel in Biotechnology (FTE). Women: Research personnel	Public Administration	4,618.2
R&D personnel in Biotechnology (FTE). Women: Research personnel	Higher Education	5,276.0
R&D personnel in Biotechnology (FTE). Women: Research personnel	Companies	4,482.6
R&D personnel in Biotechnology (FTE). Women: Research personnel	NPPI	73.9
R&D personnel in Biotechnology (FTE). Women: Technical and auxiliary personnel	Total	9,316.5
R&D personnel in Biotechnology (FTE). Women: Technical and auxiliary personnel	Public Administration	3,794.5
R&D personnel in Biotechnology (FTE). Women: Technical and auxiliary personnel	Higher Education	1,644.0
R&D personnel in Biotechnology (FTE). Women: Technical and auxiliary personnel	Companies	3,823.2
R&D personnel in Biotechnology (FTE). Women: Technical and auxiliary personnel	NPPI	54.8
Expenditure on internal R&D in Biotechnology (thousands of euros)	Total	3,143,765
Expenditure on internal R&D in Biotechnology (thousands of euros)	Public Administration	972,158
Expenditure on internal R&D in Biotechnology (thousands of euros)	Higher Education	697,028
Expenditure on internal R&D in Biotechnology (thousands of euros)	Companies	1,462,695
Expenditure on internal R&D in Biotechnology (thousands of euros)	NPPI	11,884
1) By type of expenditure: Current expenditure	Total	2,902,871
1) By type of expenditure: Current expenditure	Public Administration	903,064
1) By type of expenditure: Current expenditure	Higher Education	640,701
1) By type of expenditure: Current expenditure	Companies	1,347,574
1) By type of expenditure: Current expenditure	NPPI	11,531
1.1) Labour expenditure of research personnel	Total	1,209,348
1.1) Labour expenditure of research personnel	Public Administration	321,004
1.1) Labour expenditure of research personnel	Higher Education	413,619
1.1) Labour expenditure of research personnel	Companies	470,714
1.1) Labour expenditure of research personnel	NPPI	4,012
1.2) Labour expenditure of technical and auxiliary personnel	Total	573,196
1.2) Labour expenditure of technical and auxiliary personnel	Public Administration	216,529
1.2) Labour expenditure of technical and auxiliary personnel	Higher Education	95,990
1.2) Labour expenditure of technical and auxiliary personnel	Companies	258,791
1.2) Labour expenditure of technical and auxiliary personnel	NPPI	1,885
1.3) Other current expenditure	Total	1,120,327
1.3) Other current expenditure	Public Administration	365,530
1.3) Other current expenditure	Higher Education	131,093
1.3) Other current expenditure	Companies	618,069
1.3) Other current expenditure	NPPI	5,634
2) By type of expenditure: Capital expenditure	Total	240,894
2) By type of expenditure: Capital expenditure	Public Administration	69,094
2) By type of expenditure: Capital expenditure	Higher Education	56,327
2) By type of expenditure: Capital expenditure	Companies	115,121
2) By type of expenditure: Capital expenditure	NPPI	353
2.1) Land and buildings	Total	38,604
2.1) Land and buildings	Public Administration	5,531
2.1) Land and buildings	Higher Education	11,195
2.1) Land and buildings	Companies	21,877
2.1) Land and buildings	NPPI	0
2.2) Equipment and tools	Total	155,712
2.2) Equipment and tools	Public Administration	60,403
2.2) Equipment and tools	Higher Education	40,502
2.2) Equipment and tools	Companies	54,592
2.2) Equipment and tools	NPPI	216
2.3) Acquisition of specific R&D software	Total	8,005
2.3) Acquisition of specific R&D software	Public Administration	2,621
2.3) Acquisition of specific R&D software	Higher Education	573
2.3) Acquisition of specific R&D software	Companies	4,673
2.3) Acquisition of specific R&D software	NPPI	137
2.4) Other R&D-specific IP products	Total	38,574
2.4) Other R&D-specific IP products	Public Administration	539
2.4) Other R&D-specific IP products	Higher Education	4,057
2.4) Other R&D-specific IP products	Companies	33,978
2.4) Other R&D-specific IP products	NPPI	0
1.1) By origin of funds: Own funds	Total	1,307,305
1.1) By origin of funds: Own funds	Public Administration	183,045
1.1) By origin of funds: Own funds	Higher Education	107,514
1.1) By origin of funds: Own funds	Companies	1,013,505
1.1) By origin of funds: Own funds	NPPI	3,241
1.2) By origin of funds: Funds from the Business sector	Total	413,439
1.2) By origin of funds: Funds from the Business sector	Public Administration	155,843
1.2) By origin of funds: Funds from the Business sector	Higher Education	49,506
1.2) By origin of funds: Funds from the Business sector	Companies	206,072
1.2) By origin of funds: Funds from the Business sector	NPPI	2,019
1.3) By origin of funds: Funds from the Public Administration sector	Total	1,029,186
1.3) By origin of funds: Funds from the Public Administration sector	Public Administration	412,019
1.3) By origin of funds: Funds from the Public Administration sector	Higher Education	456,838
1.3) By origin of funds: Funds from the Public Administration sector	Companies	158,706
1.3) By origin of funds: Funds from the Public Administration sector	NPPI	1,623
1.4) By origin of funds: Funds from the Higher Education sector	Total	4,564
1.4) By origin of funds: Funds from the Higher Education sector	Public Administration	1,269
1.4) By origin of funds: Funds from the Higher Education sector	Higher Education	2,665
1.4) By origin of funds: Funds from the Higher Education sector	Companies	615
1.4) By origin of funds: Funds from the Higher Education sector	NPPI	15
1.5) By origin of funds: Funds from the Private Non-Profit Institutions sector	Total	64,269
1.5) By origin of funds: Funds from the Private Non-Profit Institutions sector	Public Administration	35,037
1.5) By origin of funds: Funds from the Private Non-Profit Institutions sector	Higher Education	18,402
1.5) By origin of funds: Funds from the Private Non-Profit Institutions sector	Companies	9,828
1.5) By origin of funds: Funds from the Private Non-Profit Institutions sector	NPPI	1,002
1.6) By origin of funds: Funds from the rest of the world	Total	325,002
1.6) By origin of funds: Funds from the rest of the world	Public Administration	184,945
1.6) By origin of funds: Funds from the rest of the world	Higher Education	62,104
1.6) By origin of funds: Funds from the rest of the world	Companies	73,969
1.6) By origin of funds: Funds from the rest of the world	NPPI	3,984
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros)	Total	166,144
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros)	Public Administration	61,567
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros)	Higher Education	8,234
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros)	Companies	96,238
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros)	NPPI	104
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In Spain	Total	126,704
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In Spain	Public Administration	53,361
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In Spain	Higher Education	7,875
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In Spain	Companies	65,364
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In Spain	NPPI	104
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In the rest of the world	Total	39,440
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In the rest of the world	Public Administration	8,206
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In the rest of the world	Higher Education	360
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In the rest of the world	Companies	30,874
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In the rest of the world	NPPI	0
% Units that consider the following obstacles to the development of biotechnologies as very important: Access to capital	Total	47.5
% Units that consider the following obstacles to the development of biotechnologies as very important: Access to capital	Public Administration	59.7
% Units that consider the following obstacles to the development of biotechnologies as very important: Access to capital	Higher Education	52.9
% Units that consider the following obstacles to the development of biotechnologies as very important: Access to capital	Companies	46.1
% Units that consider the following obstacles to the development of biotechnologies as very important: Access to capital	NPPI	76.9
% Units that consider the following obstacles to the development of biotechnologies as very important: Access to technology/information	Total	16.4
% Units that consider the following obstacles to the development of biotechnologies as very important: Access to technology/information	Public Administration	10.9
% Units that consider the following obstacles to the development of biotechnologies as very important: Access to technology/information	Higher Education	11.8
% Units that consider the following obstacles to the development of biotechnologies as very important: Access to technology/information	Companies	17.1
% Units that consider the following obstacles to the development of biotechnologies as very important: Access to technology/information	NPPI	7.7
% Units that consider the following obstacles to the development of biotechnologies as very important: Access to human resources	Total	27.4
% Units that consider the following obstacles to the development of biotechnologies as very important: Access to human resources	Public Administration	44.5
% Units that consider the following obstacles to the development of biotechnologies as very important: Access to human resources	Higher Education	35.3
% Units that consider the following obstacles to the development of biotechnologies as very important: Access to human resources	Companies	25.9
% Units that consider the following obstacles to the development of biotechnologies as very important: Access to human resources	NPPI	15.4
% Units that consider the following obstacles to the development of biotechnologies as very important: Disconnection from the value chain	Total	14.9
% Units that consider the following obstacles to the development of biotechnologies as very important: Disconnection from the value chain	Public Administration	24.4
% Units that consider the following obstacles to the development of biotechnologies as very important: Disconnection from the value chain	Higher Education	35.3
% Units that consider the following obstacles to the development of biotechnologies as very important: Disconnection from the value chain	Companies	13.4
% Units that consider the following obstacles to the development of biotechnologies as very important: Disconnection from the value chain	NPPI	7.7
% Units that consider the following obstacles to the development of biotechnologies as very important: Lack of access to international markets	Total	19.9
% Units that consider the following obstacles to the development of biotechnologies as very important: Lack of access to international markets	Public Administration	26.9
% Units that consider the following obstacles to the development of biotechnologies as very important: Lack of access to international markets	Higher Education	41.2
% Units that consider the following obstacles to the development of biotechnologies as very important: Lack of access to international markets	Companies	18.6
% Units that consider the following obstacles to the development of biotechnologies as very important: Lack of access to international markets	NPPI	15.4
% Units that consider the following obstacles to the development of biotechnologies as very important: Lack of distribution and marketing channels	Total	19.0
% Units that consider the following obstacles to the development of biotechnologies as very important: Lack of distribution and marketing channels	Public Administration	31.1
% Units that consider the following obstacles to the development of biotechnologies as very important: Lack of distribution and marketing channels	Higher Education	39.7
% Units that consider the following obstacles to the development of biotechnologies as very important: Lack of distribution and marketing channels	Companies	17.3
% Units that consider the following obstacles to the development of biotechnologies as very important: Lack of distribution and marketing channels	NPPI	7.7
% Units that consider the following obstacles to the development of biotechnologies as very important: Public acceptance/perception	Total	18.9
% Units that consider the following obstacles to the development of biotechnologies as very important: Public acceptance/perception	Public Administration	9.2
% Units that consider the following obstacles to the development of biotechnologies as very important: Public acceptance/perception	Higher Education	8.8
% Units that consider the following obstacles to the development of biotechnologies as very important: Public acceptance/perception	Companies	20.1
% Units that consider the following obstacles to the development of biotechnologies as very important: Public acceptance/perception	NPPI	23.1
% Units that consider the following obstacles to the development of biotechnologies as very important: Legal and regulatory requirements	Total	47.1
% Units that consider the following obstacles to the development of biotechnologies as very important: Legal and regulatory requirements	Public Administration	47.9
% Units that consider the following obstacles to the development of biotechnologies as very important: Legal and regulatory requirements	Higher Education	38.2
% Units that consider the following obstacles to the development of biotechnologies as very important: Legal and regulatory requirements	Companies	47.4
% Units that consider the following obstacles to the development of biotechnologies as very important: Legal and regulatory requirements	NPPI	53.9
% Units that consider the following obstacles to the development of biotechnologies as very important: Time/cost	Total	54.0
% Units that consider the following obstacles to the development of biotechnologies as very important: Time/cost	Public Administration	55.5
% Units that consider the following obstacles to the development of biotechnologies as very important: Time/cost	Higher Education	57.4
% Units that consider the following obstacles to the development of biotechnologies as very important: Time/cost	Companies	53.7
% Units that consider the following obstacles to the development of biotechnologies as very important: Time/cost	NPPI	61.5
% Units that consider the following obstacles to the development of biotechnologies as very important: Difficult access to patenting	Total	21.6
% Units that consider the following obstacles to the development of biotechnologies as very important: Difficult access to patenting	Public Administration	23.5
% Units that consider the following obstacles to the development of biotechnologies as very important: Difficult access to patenting	Higher Education	17.6
% Units that consider the following obstacles to the development of biotechnologies as very important: Difficult access to patenting	Companies	21.6
% Units that consider the following obstacles to the development of biotechnologies as very important: Difficult access to patenting	NPPI	23.1